B of A Securities Maintains Buy on Oscar Health, Raises Price Target to $25
B of A Securities Maintains Buy on Oscar Health, Raises Price Target to $25
B of A 證券維持對奧斯卡健康的買入，將目標股價上調至25美元
B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Buy and raises the price target from $22 to $25.
B of A Securities分析師亞當·羅恩維持奧斯卡健康（紐約證券交易所代碼：OSCR）的買入並將目標股價從22美元上調至25美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。